Plato Income Maximiser (PL8) Stock Price, News & Analysis

Company Overview

Listed Investment Company

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 237,466 shs
• Average Volume: N/A
• Market Capitalization: $962.00 million
• P/E Ratio: 29.16
• Dividend Yield: 5.56%
• Price Target: N/A
• Consensus Rating: N/A

PL8 Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Plato Income Maximiser own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Plato Income Maximiser investors own include Pendal Group (PDL), Australian Clinical Labs (ACL), Super Retail Group (SUL), National Australia Bank (NAB), Masimo (MASI), Lynas Rare Earths (LYC) and Immutep (IMM).

Company Calendar

• Ex-Dividend for 1/30 Dividend: 1/22/2025
• Dividend Payable: 1/30/2025
• Ex-Dividend for 2/27 Dividend: 2/12/2025
• Today: 2/23/2025
• Dividend Payable: 2/27/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: N/A
• Current Symbol: ASX:PL8
• CUSIP: N/A
• CIK: N/A
• Web: www.plato.com.au
• Phone: 1300 651 577
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): A$0.09
• Trailing P/E Ratio: 29.16
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $65.94 million
• Net Margins: 77.71%
• Pretax Margin: N/A
• Return on Equity: 8.03%
• Return on Assets: 6.52%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 50,683.75
• Quick Ratio: 1,051.82

Sales & Book Value

• Annual Sales: $84.86 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 0.95
• Book Value: A$0.55 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 748,640,000
• Free Float: N/A
• Market Cap: $962.00 million
• Optionable: Not Optionable
• Beta: 0.49